Compiled all in one place, read news articles from each of the news categories, about drugs, the pharmaceutical industry, national and international awareness causes, scientific meetings, trending stories and epgonline.org headlines.

Drug News

Added 16 hours ago Drug news

FDA accepts Opdivo + Yervoy combination for patients with previously treated advanced hepatocellular carcinoma (liver cancer). - BMS

Bristol-Myers Squibb Company announced that the FDA has accepted its supplemental Biologics License Application (sBLA) and granted Breakthrough Therapy Designation...

Added 16 hours ago Drug news

Anifrolumab demonstrated superiority across multiple efficacy endpoints in patients with systemic lupus erythematosus in phase III TULIP 2 trial. - AstraZeneca

AstraZeneca will tomorrow present detailed results from the positive Phase III TULIP 2 trial for anifrolumab, a potential new medicine...

Added 16 hours ago Drug news

Complete Response Letter from FDA to Lipocine Inc., for Tlando for testosterone replacement therapy.

Lipocine Inc. announced that it has received a Complete Response Letter from the FDA regarding its New Drug Application ("NDA")...

Added 16 hours ago Drug news

Scynexis reports positive results from first phase III (VANISH-303) registration study of oral ibrexafungerp in vulvovaginal candidiasis .

Scynexis, Inc. announced positive top-line results for its Phase III VANISH-303 study investigating the safety and efficacy of oral ibrexafungerp...

Industry news

Added 6 days ago Industry news

Stryker to acquire Wright Medical

Stryker announced a definitive agreement to acquire all of the issued and outstanding ordinary shares of Wright Medical Group N.V....

Added 26 days ago Industry news

Alexion to acquire Achillion Pharma

Alexion Pharmaceuticals, Inc.and Achillion Pharmaceuticals, Inc. announced that they have entered into a definitive agreement for Alexion to acquire Achillion,...

Added 1 month ago Industry news

UCB acquires Ra Pharmaceuticals and with it zilucoplan a proposed treatment for generalised myasthenia gravis

UCB and Ra Pharmaceuticals Inc. announced their entry into a merger agreement pursuant for which UCB will acquire Ra Pharma....